Literature DB >> 11797672

An overview of the immune system with specific reference to membrane encapsulation and islet transplantation.

D W Gray1.   

Abstract

The concept of immunoisolation by use of a bioartificial membrane is discussed, concentrating on the immunological mechanisms that are likely to be operative in the light of recent information on the workings of the immune system. Special attention is given to the use of encapsulation for the purpose of treating autoimmune diabetes by implantation of xenogeneic islet tissue. It is argued that the term immunoisolation is misleading because the immune system is always activated by the indirect pathway of antigen presentation and that the term immunomodulation would be more appropriate.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11797672     DOI: 10.1111/j.1749-6632.2001.tb03835.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  9 in total

Review 1.  Challenges and emerging technologies in the immunoisolation of cells and tissues.

Authors:  John T Wilson; Elliot L Chaikof
Journal:  Adv Drug Deliv Rev       Date:  2007-10-11       Impact factor: 15.470

Review 2.  Scaffolding in tissue engineering: general approaches and tissue-specific considerations.

Authors:  B P Chan; K W Leong
Journal:  Eur Spine J       Date:  2008-11-13       Impact factor: 3.134

Review 3.  Immune problems in central nervous system cell therapy.

Authors:  Roger A Barker; Håkan Widner
Journal:  NeuroRx       Date:  2004-10

Review 4.  Survival of encapsulated islets: More than a membrane story.

Authors:  Uriel Barkai; Avi Rotem; Paul de Vos
Journal:  World J Transplant       Date:  2016-03-24

Review 5.  Immunoisolation to prevent tissue graft rejection: Current knowledge and future use.

Authors:  Anu David; James Day; Ariella Shikanov
Journal:  Exp Biol Med (Maywood)       Date:  2016-05-02

6.  Immortalized human myoblast cell lines for the delivery of therapeutic proteins using encapsulated cell technology.

Authors:  Aurelien Lathuiliere; Remi Vernet; Emily Charrier; Muriel Urwyler; Olivier Von Rohr; Marie-Claude Belkouch; Valentin Saingier; Thomas Bouvarel; Davy Guillarme; Adrien Engel; Patrick Salmon; Thomas Laumonier; Julien Grogg; Nicolas Mach
Journal:  Mol Ther Methods Clin Dev       Date:  2022-08-01       Impact factor: 5.849

7.  Effects of PEG hydrogel crosslinking density on protein diffusion and encapsulated islet survival and function.

Authors:  Laney M Weber; Christina G Lopez; Kristi S Anseth
Journal:  J Biomed Mater Res A       Date:  2009-09-01       Impact factor: 4.396

8.  The efficacy of an immunoisolating membrane system for islet xenotransplantation in minipigs.

Authors:  Tova Neufeld; Barbara Ludwig; Uriel Barkai; Gordon C Weir; Clark K Colton; Yoav Evron; Maria Balyura; Karina Yavriyants; Baruch Zimermann; Dmitri Azarov; Shiri Maimon; Noa Shabtay; Tania Rozenshtein; Dana Lorber; Anja Steffen; Udi Willenz; Konstantine Bloch; Pnina Vardi; Ran Taube; Paul de Vos; Eli C Lewis; Stefan R Bornstein; Avi Rotem
Journal:  PLoS One       Date:  2013-08-01       Impact factor: 3.240

9.  Novel enzymatic cross-linking-based hydrogel nanofilm caging system on pancreatic β cell spheroid for long-term blood glucose regulation.

Authors:  Minji Kim; Hyunbum Kim; Young-Sun Lee; Sangjun Lee; Seong-Eun Kim; Uk-Jae Lee; Sungwon Jung; Chung-Gyu Park; Jinkee Hong; Junsang Doh; Dong Yun Lee; Byung-Gee Kim; Nathaniel S Hwang
Journal:  Sci Adv       Date:  2021-06-23       Impact factor: 14.136

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.